CannX

23/11/2022

📰Adulteration of low-delta-9-tetrahydrocannabinol products with synthetic cannabinoids

"Synthetic currently comprise the largest substance class within the group of new substances. However, data on the and of NPS, such as SCs, are generally scarce. Data on NPS are obtained through case reports and series, poison information centers, online forums, and surveys. However, the lack of analytical confirmation of the consumed product is often a serious limitation." Continue reading: https://bit.ly/3ESpWs1

26/09/2022

📰 Largest ever independent study into use

"The aim is to understand the link between a user’s biological makeup and the effect cannabis has on them. Researchers will use a combination of virtual reality, psychological and analysis, and DNA testing. The first step for participants is filling out a 40-minute survey online."
➡️ Continue reading: https://bbc.in/3eFO8n2
University of London LLM

22/07/2022

📰Δ8-THC: An Old with New Interest

"Δ8-THC was first isolated back in 1966, from an extract of the flowering tops and leaves of grown in Maryland. Its chemical structure was confirmed by comparing its optical activity and UV spectra with that of synthesized by Adam et al. in 1940, rand late via semi-synthesis from ."
➡️Read more: https://bit.ly/3OrfDNf

15/07/2022

📰Cannabis Effective at Mitigating Musculoskeletal Pain

"Patients suffering from musculoskeletal pain disorders report obtaining significant relief following their use of medical products"
➡️Read more➡️ https://bit.ly/3o6P7xK

08/06/2022

📰"Most prescribed products for chronic pain cause side effects like dizziness, but a new review has found that only those with very high , not , actually provide pain relief"
➡️Read more ➡️ https://bit.ly/3H3aNUr

Most prescribed cannabis products for chronic pain cause side effects like dizziness, but a new review has found that only those with very high THC, not CBD, actually provide pain relief

30/05/2022

📰Medical use shown to improve cancer-related symptoms
"The study findings demonstrate that MC use is associated with a significant reduction in most cancer-related symptoms during the first six months of initiating MC use."
➡️ Read more: https://bit.ly/38wzOdD

04/04/2022

04/04/2022

We were delighted to have participants from 26 different countries join us in Tel Aviv on March 14-15. Thank you for taking part in the 2022 Conference! 🙏

The conference gallery is now available on our website 👉https://bit.ly/3vbT5bR
Find yourself and share! 🤩

15/03/2022

The end of 2022 has arrived!

It has been two days full of exciting sessions, interesting with leading scientists and in the field, and an overall invaluable experience for all of us!

Thank you all for being with us and being a part of the advancement of ! 🙏

Join Yossi Bornstein, now for a closing remark!🤩

15/03/2022

We are near the end of the last day of !🤩

We hope you all had a great experience!🖐️ Join us now for a Q&A session with Dr. Nirit Bernstein, Dr. Adi Aran, and Dr. Caroline MacCallum!

15/03/2022

Plenary Session 2 - don't miss it!🤩

📆 Starting shortly at 17:55!
Hear Dr. Caroline MacCallum speaking on " safety updates: Impairment, opioids & patient complexities"!